Visit other SMART + STRONG sites:
POZREAL HEALTHTU SALUD
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Life Expectancy With HIV Increases Dramatically
HIV Eradication: One Step Closer
Scientists Crack Integrase Inhibitor Mystery
Gilead Reports Success With Quad Pill and Boosting Drug
New Hope for HIV Eradication
Study: Demand for HIV Vaccine Will Depend on How Good It Is
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

November 8, 2007

New Worries With AIDS Vaccine

Previous immunity to adenovirus 5 (Ad5), a common cold virus, may explain why volunteers receiving Merck’s preventive HIV vaccine may have been more likely to become infected with HIV than those receiving placebo injections, suggest researchers associated with the international STEP study. The new information was reported yesterday at a special gathering of HIV Vaccine Trials Network (HVTN) researchers and community advocates in Seattle.

Ad5 was used in the vaccine being developed by Merck and studied by HVTN. The shell of the virus was used as a vector to deliver pieces of HIV’s genetic material to immune system cells.

According to researchers at the meeting in Seattle, 49 male participants who received the vaccine became infected with HIV, compared with 33 males who received the placebo. There was only one infection among female participants, so they were not included in the post-study analysis. The difference in infections among the men was particularly striking when they looked at participants whose immune systems were strongly reactive to the Ad5 vector: 21 of those vaccine recipients became infected with HIV compared with just 9 who received a placebo.

The researchers cautioned that the numbers are so small and the data so new, that it is way too early to tell whether this trend toward greater HIV susceptibility in the vaccine recipients is real, or merely coincidence. They promised to continue analyzing the data with speed and intensity in hopes of answering this question as soon as possible.


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 3 (of 3 total)    

Ala Moana, bronx, NYC, 2007-11-13 22:29:39
Perhaps a prphyllactic vaccine is necessary...one that can be taken, and therefore tested, by people already infected with HIV. It's preferable to infecting healthy people.

Tim Horn, AIDSmeds.com, New York, 2007-11-13 09:04:09
Cesar- Check out of AIDSmeds.com Forums (forums.poz.com) and connect with other HIV-positive people and experts who can can possibly help you with this.

cesar figueroa, brooklyn, n.y., 2007-11-12 19:22:15
I've been pos. since 89 my meds are working for wild but then stop. My T-Cell go up and down v. lo. is in the thousands. I've never been undeteable. What should I do? I've have give up on meds. Write back.

comments 1 - 3 (of 3 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
My Cool Tools
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
Conference Coverage

17th Conference on Retroviruses and Opportunistic Infections (CROI 2010)
San Francisco, CA
February 16-19, 2010


5th IAS Conference on HIV Pathogenesis Treatment and Prevention (IAS 2009)
Cape Town, South Africa
July 19-22, 2009


16th Conference on Retroviruses and Opportunistic Infections (CROI 2009)
Montréal, Canada
February 8-11, 2009

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2010 Smart + Strong. All Rights Reserved. Terms of use and Your privacy